Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy.

Aaron DotsonAllison MayFacundo DavaroSyed Johar RazaSameer SiddiquiZachary Hamilton

Published in: International journal of clinical oncology (2019)

Analysis of a national tumor registry suggests a lack of overall survival benefit for NAC with localized, muscle invasive SCC of the bladder. Further research directed at chemotherapy regimens for SCC is needed to optimize treatment and improve survival outcomes.

Keyphrases

neoadjuvant chemotherapy
locally advanced
squamous cell carcinoma
rectal cancer
spinal cord injury
sentinel lymph node
lymph node
radiation therapy
transcription factor
skeletal muscle
quality improvement
lymph node metastasis
combination therapy
early stage